SYP and Alzheimer disease: Likewise, there were decreased SNAP-5 levels in five brain regions of patients with Alzheimer’s disease [304] and a 25% reduction of synaptophysin levels in the frontal cortex of patients with early Alzheimer’s disease compared with controls [305].